Shire Share Discussion Threads

[philanderer] 06/4/2018 18:03

RNS from Takeda..


Takeda Statement Regarding Press Reports


Cambridge, Mass. and Osaka, Japan, 6 April, 2018

Takeda Pharmaceutical Company Limited ("Takeda") notes media reports about comments attributed to Takeda's CEO Christophe Weber regarding the company's possible offer for Shire plc ("Shire"). Takeda confirms that Mr Weber's comments were, however, aligned with the statements in our previous press releases.

As set out in the press releases "Takeda Statement Regarding Shire plc" on March 28, 2018 in English and "Takeda's official statement on Shire's stock fluctuation" on March 29, 2018 in Japanese, clearly defined strategic and financial objectives are core to Takeda's disciplined approach to acquisitions, including in relation to its dividend policy and credit rating, which are well-established. Any potential offer for Shire, if made, would have to align with this strict investment criteria.

[philanderer] 06/4/2018 17:38

Takeda move for Shire looks increasingly likely

A survey of Shire investors showed that they would be looking for a buyout worth £45 per share and would want less than half of the acquisition to be made up of Takeda shares.

The interesting point to watch now, after Takeda seems willing and able to make the move for Shire, will be whether any other companies jump into the race.

[arja] 06/4/2018 16:22

not exactly storming aheadtoday after a bright start - punters are far from sure a
deal will eventuate !should be good day trading opportunities in the days ahead

[toffeeman] 06/4/2018 15:26

FLYB had an offer a few weeks back and did not inform shareholders of the price!

[karateboy] 06/4/2018 15:06

If an offer is made, SHP should inform the market as soon as possible as that is price sensitive information. My guess is that an offer could be made when market is closed to allow SHP to absorb the offer and issue an RNS on Monday.

[philanderer] 06/4/2018 13:49

FT Alphaville couple of hours ago...


Shire PLC (SHP:LSE): Last: 3,761, up 53.5 (+1.44%), High: 3,794, Low: 3,716, Volume: 714.64k

BE
Wednesday night's analyst meeting was covered in full in this morning's papers.

BE
Some surprise in some quarters that Takeda spoke reasonably openly about the bid process, within the limits of the Code.

BE
That, plus talk around of buyside being sounded out, might lead a person to believe that the formal offer will be going in sooner rather than later.

BE
In fact, it might already be in. Don't think Shire would have to update us immediately if that were the case.

BE
Though you'd hope for an update quite soon, right? And me typing this here might hurry along the process a tad if a formal offer is in, right?

[demo trader] 06/4/2018 09:34

TO BE OR NOT TO BE...... make up your mind Takeda !


Takeda Initiates World's First Norovirus Vaccine Field Trial.

[philanderer] 06/4/2018 08:57

ECONOMIST article

5th april

Takeda eyes up Shire

Japan’s biggest drugmaker is weighing a record purchase

[karateboy] 06/4/2018 08:43

According to yesterday news, majority of investors happy to close the deal with Takeda for £45 a share and move on. However in my opinion if there is another bidder, we are talking at least £50 a share.

[ruethewhirl] 06/4/2018 07:41

Hmm, think Ornskov and the rest think Shire's worth a lot.

I reckon 45+ is definitely on.

Note: Takeda is tanking. Down %5 today.

[arja] 06/4/2018 07:38

dreaming there I suspect but maybe 45 is a possibility .

[hortensius] 06/4/2018 07:14

Pfe selling major consumer health assets and downgraded by Barclays due to a lack of a “transformative acquisition” they could easily afford shp and would tick a lot of boxes

£55 Bid quite soon would really make my year so far

[ruethewhirl] 06/4/2018 02:08

Be very surprised if another bidder does not step forward to trump Takeda.

Endless speculation over the last few years, tbh be strange if it all came to nothing.

I think Takeda could easily be outgunned by a bigger player, and if the Takeda deal happens then she's off the market once and for all boys, so step up.

[ruethewhirl] 06/4/2018 01:42

Bold move by Takeda, CEO seems super bullish, sounds a bit like hubris to me but who cares.

Show us the money :)

[philanderer] 06/4/2018 00:09

Market report: Shire shored up by suitor’s confidence


Deal-hungry traders lifted pharma takeover target Shire to a fresh three-month high after Japanese suitor Takeda laid the groundwork for a bid.

In a meeting with analysts in Tokyo, Takeda boss Christophe Weber insisted that the deal size did not intimidate his company. It would attempt to snap up the entirety of Shire despite the company’s £32bn valuation surging past Takeda’s when it revealed its interest last week, he said.

According to UBS, Mr Weber explained that a tie-up for Shire would accelerate Takeda’s transformation and he insisted that a deal could be made without threatening the company’s dividend and credit rating.

The French boss told analysts that a deal would help Takeda reach its “Vision 2025” goal sooner than anticipated, and Shire would fit well in the Osaka-based company’s portfolio.

With Takeda’s bid deadline less than three weeks away, Shire climbed a further 107p, or 3pc, to £37.07 on rising expectations of a huge swoop.

[philanderer] 06/4/2018 00:07

Trump Orders Consideration of $100 Billion in New China Tariffs


President Donald Trump said Thursday he is ordering the U.S. Trade Representative to consider $100 billion in additional tariffs on Chinese goods.

“In light of China’s unfair retaliation, I have instructed the USTR to consider whether $100 billion of additional tariffs would be appropriate under section 301 and, if so, to identify the products upon which to impose such tariffs,” Trump said in a statement issued by the White House.

[philanderer] 06/4/2018 00:05

IGSquawk @IGSquawk

5 minutes ago

Trump orders trade representatives to consider $100B in trade tariffs on China. US indices drop 1%


At present..


DJ futures -400pts

FTSE fut -70pts

[ruethewhirl] 05/4/2018 22:10

Rising sp, rising volume.

I like it.

[philanderer] 05/4/2018 21:13

FT:

Shire was in demand after Takeda, its potential acquirer, hosted an analyst meeting to address concerns about the deal’s size and strategic rationale.

Christophe Weber, Takeda’s chief executive, was reported by analysts who attended as saying that buying Shire would accelerate the Japanese group’s transformation and that it can afford a deal without sacrificing its investment-grade credit rating or dividend.

[demo trader] 05/4/2018 12:36

Easy in Japan to raise money for smaller company to takeover bigger.




Sanford C. Bernstein, which sees Shire as a ‘buy,’ set a price target of 4,400p on the stock this week, while Societe Generale, which also has a ‘buy’ rating on the rare disease specialist, set a valuation of 7,500p on the shares. According to MarketBeat, the blue-chip pharmco currently has a consensus ‘buy’ rating and an average price target of 4,683.33p.

[romeike] 05/4/2018 12:12

[extract re:Takeda CEO comments].... but what he did say was that Takeda is interested in buying the whole company, it's strategically important for the current plan though not essential, and he'll stretch the balance sheet in the short term to get it done.

Fact is they can't afford the whole company. Simple as that.

[philanderer] 05/4/2018 12:03

Similar to zho's Alphaville link...


Shire was was the standout gainer on the FTSE 100 as Credit Suisse said the overnight analyst call regarding Japanese drug maker Takeda suggested that CEO Christophe Weber is strongly committed to making an offer for the group.

[romeike] 05/4/2018 11:18

hxxps://www.thepharmaletter.com/in-brief/brief-takeda-to-sell-brazil-subsidiary

Japan’s Takeda Pharmaceutical has signed an agreement with Novamed Fabricação de Produtos Farmacêuticos to sell/divest all shares, and all its assets in its 110%-owned Brazilian subsidiary Multilab Indústria e Comércio de Produtos Farmacêuticos to Novamed.

The deal’s value is not disclosed.

[soundbuy] 05/4/2018 09:08

Takeda's paper worth a tad more............